Results
|
|
1021.
|
A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. [electronic resource] by
- Maddocks, Kami
- Hertlein, Erin
- Chen, Timothy L
- Wagner, Amy J
- Ling, Yonghua
- Flynn, Joseph
- Phelps, Mitch
- Johnson, Amy J
- Byrd, John C
- Jones, Jeffrey A
Producer: 20180319
In:
Leukemia & lymphoma vol. 57
Availability: No items available.
|
|
|
1022.
|
|
|
|
1023.
|
|
|
|
1024.
|
|
|
|
1025.
|
|
|
|
1026.
|
|
|
|
1027.
|
|
|
|
1028.
|
|
|
|
1029.
|
|
|
|
1030.
|
|
|
|
1031.
|
|
|
|
1032.
|
|
|
|
1033.
|
|
|
|
1034.
|
|
|
|
1035.
|
|
|
|
1036.
|
|
|
|
1037.
|
|
|
|
1038.
|
|
|
|
1039.
|
A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. [electronic resource] by
- Pacey, Simon
- Wilson, Richard H
- Walton, Mike
- Eatock, Martin M
- Hardcastle, Anthea
- Zetterlund, Anna
- Arkenau, Hendrik-Tobias
- Moreno-Farre, Javier
- Banerji, Udai
- Roels, Belle
- Peachey, Heidi
- Aherne, Wynne
- de Bono, Johan S
- Raynaud, Florence
- Workman, Paul
- Judson, Ian
Producer: 20110722
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17
Availability: No items available.
|
|
|
1040.
|
|